Hooked Up from a Distance: Charting Genome-Wide Long-Range Interaction Maps in Neural Cells Chromatin to Identify Novel Candidate Genes for Neurodevelopmental Disorders.

CRISPR-Cas9 DNA sequence variants chromatin enhancers gene regulation long-range interactions neurodevelopmental disorders (NDD)

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
06 Jan 2023
Historique:
received: 30 11 2022
revised: 31 12 2022
accepted: 02 01 2023
entrez: 21 1 2023
pubmed: 22 1 2023
medline: 25 1 2023
Statut: epublish

Résumé

DNA sequence variants (single nucleotide polymorphisms or variants, SNPs/SNVs; copy number variants, CNVs) associated to neurodevelopmental disorders (NDD) and traits often map on putative transcriptional regulatory elements, including, in particular, enhancers. However, the genes controlled by these enhancers remain poorly defined. Traditionally, the activity of a given enhancer, and the effect of its possible alteration associated to the sequence variants, has been thought to influence the nearest gene promoter. However, the obtainment of genome-wide long-range interaction maps in neural cells chromatin challenged this view, showing that a given enhancer is very frequently not connected to the nearest promoter, but to a more distant one, skipping genes in between. In this Perspective, we review some recent papers, who generated long-range interaction maps (by HiC, RNApolII ChIA-PET, Capture-HiC, or PLACseq), and overlapped the identified long-range interacting DNA segments with DNA sequence variants associated to NDD (such as schizophrenia, bipolar disorder and autism) and traits (intelligence). This strategy allowed to attribute the function of enhancers, hosting the NDD-related sequence variants, to a connected gene promoter lying far away on the linear chromosome map. Some of these enhancer-connected genes had indeed been already identified as contributive to the diseases, by the identification of mutations within the gene's protein-coding regions (exons), validating the approach. Significantly, however, the connected genes also include many genes that were not previously found mutated in their exons, pointing to novel candidate contributors to NDD and traits. Thus, long-range interaction maps, in combination with DNA variants detected in association with NDD, can be used as "pointers" to identify novel candidate disease-relevant genes. Functional manipulation of the long-range interaction network involving enhancers and promoters by CRISPR-Cas9-based approaches is beginning to probe for the functional significance of the identified interactions, and the enhancers and the genes involved, improving our understanding of neural development and its pathology.

Identifiants

pubmed: 36674677
pii: ijms24021164
doi: 10.3390/ijms24021164
pmc: PMC9863356
pii:
doi:

Substances chimiques

Chromatin 0
DNA 9007-49-2

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Science. 2009 Oct 9;326(5950):289-93
pubmed: 19815776
Stem Cells. 2021 Aug;39(8):1107-1119
pubmed: 33739574
Science. 2022 Aug 19;377(6608):eabi8654
pubmed: 35981026
Curr Biol. 2016 Jan 11;26(1):38-51
pubmed: 26687625
J Vis Exp. 2010 May 06;(39):
pubmed: 20461051
Nat Genet. 2019 Aug;51(8):1252-1262
pubmed: 31367015
Nature. 2009 Nov 5;462(7269):58-64
pubmed: 19890323
Science. 2012 Sep 7;337(6099):1190-5
pubmed: 22955828
Science. 2019 Nov 29;366(6469):1134-1139
pubmed: 31727856
Nature. 2017 Sep 13;549(7671):219-226
pubmed: 28905911
Science. 2016 Nov 11;354(6313):769-773
pubmed: 27708057
J Med Chem. 2014 Aug 28;57(16):6930-48
pubmed: 24831826
Nat Rev Genet. 2013 Jun;14(6):390-403
pubmed: 23657480
N Engl J Med. 2021 Jan 21;384(3):252-260
pubmed: 33283989
Nat Genet. 2015 Mar;47(3):291-5
pubmed: 25642630
Nature. 2020 Feb;578(7794):229-236
pubmed: 32051598
Nat Rev Genet. 2020 May;21(5):292-310
pubmed: 31988385
Nature. 2020 Nov;587(7835):644-649
pubmed: 33057195
Nat Neurosci. 2019 Apr;22(4):524-528
pubmed: 30858603
Open Biol. 2021 Feb;11(2):200339
pubmed: 33622105
Nat Neurosci. 2016 Jan;19(1):75-83
pubmed: 26595656
Nature. 2020 Jul;583(7818):699-710
pubmed: 32728249
N Engl J Med. 2019 Jul 4;381(1):64-74
pubmed: 31269367
Nature. 2012 Sep 6;489(7414):57-74
pubmed: 22955616
Nature. 2012 Apr 11;485(7398):381-5
pubmed: 22495304
Trends Mol Med. 2021 Nov;27(11):1060-1073
pubmed: 34420874
Nat Protoc. 2021 Sep;16(9):4144-4176
pubmed: 34373652
Cell Res. 2016 Dec;26(12):1345-1348
pubmed: 27886167
Nat Neurosci. 2009 Oct;12(10):1248-56
pubmed: 19734891
Nat Rev Mol Cell Biol. 2020 Oct;21(10):571-584
pubmed: 32636524
Cell. 2019 Jan 10;176(1-2):377-390.e19
pubmed: 30612741
Nature. 2013 Dec 12;504(7479):306-310
pubmed: 24213634
Nature. 2016 Oct 27;538(7626):523-527
pubmed: 27760116
Nature. 2012 Apr 11;485(7398):376-80
pubmed: 22495300
Science. 2018 Dec 14;362(6420):
pubmed: 30545851
Genome Biol. 2015 Aug 03;16:156
pubmed: 26313521
Nature. 2021 Oct;598(7879):129-136
pubmed: 34616068
Nat Genet. 2019 Dec;51(12):1664-1669
pubmed: 31784727
Nature. 2021 Jul;595(7869):735-740
pubmed: 34040254
Nat Protoc. 2013 Nov;8(11):2281-2308
pubmed: 24157548
Mol Cell. 2016 Jun 2;62(5):668-80
pubmed: 27259200
Nat Genet. 2019 Oct;51(10):1442-1449
pubmed: 31501517
Int J Mol Sci. 2022 Jul 19;23(14):
pubmed: 35887306
Nucleic Acids Res. 2014 Jan;42(Database issue):D1001-6
pubmed: 24316577
Trends Neurosci. 2019 Feb;42(2):115-127
pubmed: 30563709
Nature. 2021 May;593(7858):238-243
pubmed: 33828297
Cell Stem Cell. 2019 Mar 7;24(3):462-476.e6
pubmed: 30849367

Auteurs

Sara Mercurio (S)

Department of Biotechnology and Biosciences, University of Milano-Bicocca, piazza della Scienza 2, 20126 Milano, Italy.

Giorgia Pozzolini (G)

Department of Biotechnology and Biosciences, University of Milano-Bicocca, piazza della Scienza 2, 20126 Milano, Italy.

Roberta Baldi (R)

Department of Biotechnology and Biosciences, University of Milano-Bicocca, piazza della Scienza 2, 20126 Milano, Italy.

Sara E Barilà (SE)

Department of Biotechnology and Biosciences, University of Milano-Bicocca, piazza della Scienza 2, 20126 Milano, Italy.

Mattia Pitasi (M)

Department of Biotechnology and Biosciences, University of Milano-Bicocca, piazza della Scienza 2, 20126 Milano, Italy.

Orazio Catona (O)

Institute of Informatics and Telematics (IIT), National Research Council (CNR), 56124 Pisa, Italy.

Romina D'Aurizio (R)

Institute of Informatics and Telematics (IIT), National Research Council (CNR), 56124 Pisa, Italy.

Silvia K Nicolis (SK)

Department of Biotechnology and Biosciences, University of Milano-Bicocca, piazza della Scienza 2, 20126 Milano, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH